- Home
- KRRO
KRRO
Korro Bio Inc.
as 11-28-2025 12:21pm EST
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 58.6M | IPO Year: | 2019 |
| Target Price: | $74.17 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.42 - $56.69 | Next Earning Date: | 11-12-2025 |
| Revenue: | $7,371,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 116.91% | Revenue Growth (next year): | -59.05% |
Latest Korro Bio Inc. News
KRRO Breaking Stock News: Dive into KRRO Ticker-Specific Updates for Smart Investing
Simply Wall St.
14 days ago
Korro Bio (KRRO): Assessing Valuation After Clinical Setbacks, Layoffs, and Strategic Pivot
Investor's Business Daily
15 days ago
Korro Bio Plummets To A Record Low On A Big Setback In RNA Editing
MT Newswires
15 days ago
Top Midday Decliners
The Fly
15 days ago
Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls
MT Newswires
15 days ago
Korro Bio's Pivot to GaINac Pragmatic After 'Disappointing' KRRO-110 Data, RBC Says
MT Newswires
15 days ago
Cantor Fitzgerald Downgrades Korro Bio to Neutral From Overweight
MT Newswires
15 days ago
Chardan Downgrades Korro Bio to Neutral From Buy, Slashes Price Target to $7 From $25
MT Newswires
15 days ago
HC Wainwright Downgrades Korro Bio to Neutral From Buy
Compare KRRO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KRRO Korro Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.